EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Matrix Metalloproteinase Inhibitors and Their Potential Clinical Application in Periodontitis

Daniela Mendoza-Juárez, Manuel Sánchez-Gutiérrez, Aleli Julieta Izquierdo-Vega, Eduardo Osiris Madrigal-Santillán iD, Claudia Velázquez-González, Jeannett Alejandra Izquierdo-Vega iD

Diseases · 06.09.2025 · 13 (9) · 296

DOI: 10.3390/diseases13090296 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diseases, online erschienen am 06.09.2025. Verfasst von Daniela Mendoza-Juárez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Academic Area of Medicine, Institute of Health Sciences, Autonomous University of the State of Hidalgo, Ex-hacienda la Concepción, Tilcuautla 42160, …. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondos Estatales Genéricos de la Universidad Autónoma del Estado de Hidalgo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Matrix metalloproteinases (MMPs) are a family of endopeptidases recognized for their involvement in the degradation of the extracellular matrix and their important role in the pathogenesis of periodontitis. This chronic inflammatory condition causes the degradation of dental supporting tissues, resulting in bone loss. In patients with periodontitis, the expression and activation of MMPs, especially MMP-8 and MMP-9, significantly influence tissue degradation. In periodontitis treatment, various natural or synthetic metalloproteinase inhibitors (MMPIs) and antibiotics are used in sub-antimicrobial doses. However, while the evidence supports a role for MMPIs in reducing inflammation, preserving connective tissue, and improving the results of conventional periodontitis treatment, their clinical application is limited. In this review, we summarize MMPIs, their characteristics, and the mechanisms of action that may support their use in the treatment of periodontitis. In conclusion, MMPIs are a therapeutic alternative with great potential in the management of periodontitis, especially when combined with mechanical treatments, although further research is needed to optimize their clinical use.

Schlagwörter

Stichwörter der Autor:innen

metalloproteinase inhibitorsmetalloproteinasesperiodontitis

Autor:innen und Institutionen

  • Academic Area of Medicine, Institute of Health Sciences, Autonomous University of the State of Hidalgo, Ex-hacienda la Concepción, Tilcuautla 42160, Mexico.
  • Academic Area of Pharmacy, Institute of Health Sciences, Autonomous University of the State of Hidalgo, Ex-Hacienda la Concepción, Tilcuautla 42160, Mexico.

ORCID-Profile: Eduardo Osiris Madrigal-Santillán, Jeannett Alejandra Izquierdo-Vega

Förderung

  • Fondos Estatales Genéricos de la Universidad Autónoma del Estado de Hidalgo

Zitieren

APA

Mendoza-Juárez, D., Sánchez-Gutiérrez, M., Izquierdo-Vega, A. J., Madrigal-Santillán, E. O., Velázquez-González, C., & Izquierdo-Vega, J. A. (2025). Matrix Metalloproteinase Inhibitors and Their Potential Clinical Application in Periodontitis. Diseases, 13(9), 296. https://doi.org/10.3390/diseases13090296

Vancouver

Mendoza-Juárez D, Sánchez-Gutiérrez M, Izquierdo-Vega AJ, Madrigal-Santillán EO, Velázquez-González C, Izquierdo-Vega JA. Matrix Metalloproteinase Inhibitors and Their Potential Clinical Application in Periodontitis. Diseases. 2025;13(9):296. doi:10.3390/diseases13090296

BibTeX
@article{MendozaJurez2025,
  author = {Mendoza-Juárez, Daniela and Sánchez-Gutiérrez, Manuel and Izquierdo-Vega, Aleli Julieta and Madrigal-Santillán, Eduardo Osiris and Velázquez-González, Claudia and Izquierdo-Vega, Jeannett Alejandra},
  title = {Matrix Metalloproteinase Inhibitors and Their Potential Clinical Application in Periodontitis},
  journal = {Diseases},
  year = {2025},
  volume = {13},
  number = {9},
  pages = {296},
  doi = {10.3390/diseases13090296}
}
Kostenlos starten →